BL n = 53 | |||||
---|---|---|---|---|---|
Clinical status of the disease | Cases confirmed by AFB In SSS(Slit skin smear) | Cases confirmed by Multiplex-PCR | Percent of positivity by AFB test | Percent of positivity of M-PCR test | |
 | BI | No of case |  |  |  |
Patients without treatment (New Cases)(n = 44) | 2 | 23 | 23 | 100% | 100% |
 | 3 | 11 | 11 |  |  |
 | 4 | 10 | 10 |  |  |
Patients on treatment not more than 2 months (n = 5) | 0 | 4 | 2(50%) | 25% | 60% |
 | 2 | 1 | 1 |  |  |
 | 3 | 0 | 0 |  |  |
 | 4 | 0 | 0 |  |  |
Patients released from treatment (RFT)(a)/later developed a new active lesion/relapsed cases(b) (n = 4) | 0 | 2a, | 2(0%) | 50% | 50% |
 | 2 | 1a | 1a |  |  |
 | 3 | 1b | 1b |  |  |
Total n = 53 | Â | Â | Â | 71.6% (38/53) | 88.67% (47/53) |
LL n = 152 | |||||
Clinical status of the disease | Cases confirmed by AFB In SSS(Slit skin smear) | Cases confirmed by Multiplex-PCR | Percent of positivity by AFB test | Percent of positivity of M-PCR test | |
 | BI | No of case |  |  |  |
Patients without treatment (New Cases)(n = 115) | 2 | 8 | 8 | 100% | 100% |
 | 3 | 35 | 35 |  |  |
 | 4 | 37 | 37 |  |  |
 | 5 | 31 | 31 |  |  |
 | 6 | 4 | 4 |  |  |
Patients on treatment not more than 2 months (n = 12) | 0 | 4 | 1(25%) | 66.66% | 75% |
 | 2 | 3 | 3 |  |  |
 | 3 | 2 | 2 |  |  |
 | 4 | 3 | 3 |  |  |
 | 5 | 0 | 0 |  |  |
 | 6 | 0 | 0 |  |  |
Patients released from treatment (RFT)(a)/later developed a new active lesion/relapsed cases(b) (n = 25) | 0 | 14a,1b | 2(13.33%) | 40% | 48% |
 | 2 | 1a,2b | 3 |  |  |
 | 3 | 2b | 2 |  |  |
 | 4 | 2a,1b | 3 |  |  |
 | 5 | 1a | 1 |  |  |
 | 6 | 1a | 1 |  |  |
Total n = 152 | Â | Â | Â | 83.4% (133/152) | 89.2% (136/152) |